IP Library Granted Patent US 10,017,542
Granted Patent B2
US 10,017,542 · App. 15/078,794 · Granted Jul 10, 2018

Antimicrobial peptides and methods of use thereof

Inventors: Jesse Jaynes (Auburn, CA); L. Edward Clemens (Sacramento, CA); Henry W. Lopez (Napa, CA); George R. Martin (Rockville, MD); Kathryn Woodburn (Saratoga, CA)
Assignee: Riptide Bioscience, Inc.
C07K14/00A61K45/06C07K7/06C07K7/08A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,017,542
App. No.
15/078,794
Granted
Jul 10, 2018
Kind
B2
Abstract

Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.

Claims (36)

1. An antimicrobial composition comprising an antimicrobial peptide, wherein the antimicrobial peptide comprises an amino acid sequence having at least 90% sequence identity to one of SEQ ID NOs: 3, 5, 8, 18, 22, 23 and 25-30.

2. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises a hydrophobic tail region on the N-terminus, C-terminus, or both, and wherein the hydrophobic tail region has a sequence of from 4 to 10 hydrophobic amino acids.

3. The antimicrobial composition of claim 2 , wherein the hydrophobic tail region consists of the amino acid sequence set forth in SEQ ID NO: 4.

4. The antimicrobial composition of claim 3 , wherein the antimicrobial peptide comprises an amino acid sequence selected from SEQ ID NOs: 22 and 23.

5. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises an amino acid sequence selected from SEQ ID NOs: 8, 18 and 27.

6. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises two amphipathic regions that form a dimer.

7. The antimicrobial composition of claim 6 , wherein the two amphipathic regions have the same amino acid sequence.

8. The antimicrobial composition of claim 6 , wherein the two amphipathic regions have different amino acid sequences.

9. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises an amino acid sequence having at least 95% sequence identity to one of SEQ ID NOs: 3, 5, 8, 18, 22, 23 and 25-30.

10. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 23.

11. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 22.

12. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 3, 5, 8, 18, 22, 23 and 25-30.

13. The antimicrobial composition of claim 1 , wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 27.

14. A pharmaceutical composition comprising the antimicrobial composition of claim 1 and a pharmaceutically acceptable carrier.

15. The pharmaceutical composition of claim 14 , wherein the composition is formulated for oral administration, parenteral administration, or topical administration.

16. The pharmaceutical composition of claim 15 , wherein the composition is formulated for oral administration and further comprises an enteric coating.

17. The pharmaceutical composition of claim 15 , wherein the composition is formulated for topical delivery in a form selected from the group consisting of: a gel suspension, a cream, microneedle, and infused into a bandage or topical patch.

18. The pharmaceutical composition of claim 14 , further comprising an additional bioactive agent.

19. The pharmaceutical composition of claim 18 , wherein the additional bioactive agent is selected from the group consisting of: an antimicrobial agent, an anti-inflammatory drug, an anti-nausea drug, an anti-pain medication, and combinations thereof.

20. The pharmaceutical composition of claim 14 , wherein the composition is formulated to be coated on the surface of an implantable medical device.

21. The pharmaceutical composition of claim 20 , wherein the medical device is selected from the group consisting of: surgical instruments and indwelling medical devices.

22. An antimicrobial composition comprising an antimicrobial peptide, wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 21.

23. An antimicrobial composition comprising an antimicrobial peptide, wherein the antimicrobial peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 6 and 20.

24. The antimicrobial composition of claim 23 , wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 20.

25. The antimicrobial composition of claim 23 , wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 6.

26. An antimicrobial composition comprising an antimicrobial peptide, wherein the antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 19.

27. A pharmaceutical composition comprising the antimicrobial composition of claim 10 and a pharmaceutically acceptable carrier.

28. The pharmaceutical composition of claim 27 , wherein the composition is formulated for oral administration, parenteral administration, or topical administration.

29. The pharmaceutical composition of claim 28 , wherein the composition is formulated for topical delivery in a form selected from the group consisting of: a gel suspension, a cream, microneedle, and infused into a bandage or topical patch.

30. The pharmaceutical composition of claim 27 , wherein the composition is formulated to be coated on the surface of an implantable medical device.

31. The pharmaceutical composition of claim 30 , wherein the medical device is selected from the group consisting of: surgical instruments and indwelling medical devices.

32. A pharmaceutical composition comprising the antimicrobial composition of claim 13 and a pharmaceutically acceptable carrier.

33. The pharmaceutical composition of claim 32 , wherein the composition is formulated for oral administration, parenteral administration, or topical administration.

34. The pharmaceutical composition of claim 33 , wherein the composition is formulated for topical delivery in a form selected from the group consisting of: a gel suspension, a cream, microneedle, and infused into a bandage or topical patch.

35. The pharmaceutical composition of claim 32 , wherein the composition is formulated to be coated on the surface of an implantable medical device.

36. The pharmaceutical composition of claim 35 , wherein the medical device is selected from the group consisting of: surgical instruments and indwelling medical devices.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2017
From: WOODBURN, KATHRYN
To: RIPTIDE BIOSCIENCE, INC.
Reel/Frame 042635/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2016
From: JAYNES, JESSE; CLEMENS, L. EDWARD; LOPEZ, HENRY WILFRED; MARTIN, GEORGE R.
To: RIPTIDE BIOSCIENCE, INC.
Reel/Frame 038258/0290 →
Continuity (2)
Provisional Application 62137206 · Mar 23, 2015
Related Publication 20160296594A1 · Oct 13, 2016
Cited By (1)
US 12,564,617